Highlights
KLSE: GENTING (3182)       GENTING BHD MAIN : Consumer
Last Price Today's Change   Day's Range   Trading Volume
4.45   -0.04 (0.89%)  4.45 - 4.54  6,716,600
Trade this stock and win a FREE I3investor T-shirt after 5 trades. Find out more.

Financials


Market Cap: 17,252 Million

Market Cap 17,252 Million
NOSH 3,877 Million

Latest Audited Result:  31-Dec-2023

Latest Audited Result: 31-Dec-2023
Announcement Date 19-Apr-2024
Next Audited Result: 31-Dec-2024
Est. Ann. Date: 19-Apr-2025
Est. Ann. Due Date: 29-Jun-2025

Latest Quarter:  31-Dec-2023 [#4]

Latest Quarter: 31-Dec-2023 [#4]
Announcement Date 29-Feb-2024
Next Quarter: 31-Mar-2024
Est. Ann. Date: 25-May-2024
Est. Ann. Due Date: 30-May-2024
QoQ | YoY   -71.16%  |    188.96%

Annual (Unaudited) ( EPS: 23.97, P/E: 18.57 )

Revenue | NP to SH 27,118,560  |  929,201
RPS | P/RPS 699.49 Cent  |  0.64
EPS | P/E | EY 23.97 Cent  |  18.57  |  5.39%
DPS | DY | Payout % 14.90 Cent  |  3.35%  |  62.16%
NAPS | P/NAPS 8.69  |  0.51
YoY   409.83%
NP Margin | ROE 8.36%  |  2.76%
F.Y. | Ann. Date 31-Dec-2023  |  29-Feb-2024

T4Q Result ( EPS: 23.97, P/E: 18.57 )

Revenue | NP to SH 27,118,560  |  929,201
RPS | P/RPS 699.49 Cent  |  0.64
EPS | P/E | EY 23.97 Cent  |  18.57  |  5.39%
DPS | DY | Payout % 14.90 Cent  |  3.35%  |  62.16%
NAPS | P/NAPS 8.69  |  0.51
QoQ | YoY   52.23%  |    409.83%
NP Margin | ROE 8.36%  |  2.76%
F.Y. | Ann. Date 31-Dec-2023  |  29-Feb-2024

Annualized Result ( EPS: 23.97, P/E: 18.57 )

Revenue | NP to SH 27,118,560  |  929,201
RPS | P/RPS 699.49 Cent  |  0.64
EPS | P/E | EY 23.97 Cent  |  18.57  |  5.39%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   -10.55%  |    409.83%
NP Margin | ROE 8.36%  |  2.76%
F.Y. | Ann. Date 31-Dec-2023  |  29-Feb-2024


Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.

Click here to modify the Visible Columns.

Date Financial Result Financial Ratio Per Share Item Performance Valuation (End of Quarter) Valuation (Ann. Date)
F.Y. Ann. Date Quarter # Revenue PBT NP NP to SH Div Net Worth Div Payout % NP Margin ROE NOSH RPS Adj. RPS EPS Adj. EPS DPS Adj. DPS NAPS Adj. NAPS QoQ YoY EOQ Date EOQ Price EOQ P/RPS EOQ P/EPS EOQ P/NAPS EOQ EY EOQ DY ANN Date ANN Price ANN P/RPS ANN P/EPS ANN P/NAPS ANN EY ANN DY
31-Dec-2023 29-Feb-2024 31-Dec-2023 4 7,267,363 865,551 529,536 150,099 346,554 33,692,750 230.88% 7.29% 0.45% 3,850,600 188.73 187.45 3.90 3.87 9.00 8.94 8.7500 8.69   -71.16%   188.96% 29-Dec-2023 4.62 2.45 118.52 0.53 0.84% 1.95% 29-Feb-2024 4.77 2.53 122.37 0.55 0.82% 1.89%
31-Dec-2023 23-Nov-2023 30-Sep-2023 3 7,369,538 1,391,003 995,072 520,518 - 33,461,712 - % 13.50% 1.56% 3,850,600 191.39 190.09 13.52 13.43 0.00 0.00 8.6900 8.63   224.21%   306.58% 29-Sep-2023 4.17 2.18 30.85 0.48 3.24% 0.00% 23-Nov-2023 4.36 2.28 32.25 0.50 3.10% 0.00%
31-Dec-2023 24-Aug-2023 30-Jun-2023 2 6,659,151 742,480 447,433 160,548 231,036 33,269,185 143.90% 6.72% 0.48% 3,850,600 172.94 171.77 4.17 4.14 6.00 5.96 8.6400 8.58   63.76%   369.67% 30-Jun-2023 4.06 2.35 97.38 0.47 1.03% 1.48% 4.41 2.55 105.77 0.51 0.95% 1.36%
31-Dec-2023 25-May-2023 31-Mar-2023 1 5,822,508 568,003 295,191 98,036 - 31,767,450 - % 5.07% 0.31% 3,850,600 151.21 150.18 2.55 2.53 0.00 0.00 8.2500 8.19   158.11%   149.10% 31-Mar-2023 4.66 3.08 183.03 0.56 0.55% 0.00% 25-May-2023 4.33 2.86 170.07 0.52 0.59% 0.00%
31-Dec-2022 23-Feb-2023 31-Dec-2022 4 6,361,852 119,769 -251,308 -168,718 346,554 31,690,436 - % -3.95% -0.53% 3,850,600 165.22 164.10 -4.38 -4.35 9.00 8.94 8.2300 8.17   -231.79%   -29.98% 30-Dec-2022 4.48 2.71 -102.25 0.54 -0.98% 2.01% 4.71 2.85 -107.49 0.57 -0.93% 1.91%
31-Dec-2022 24-Nov-2022 30-Sep-2022 3 6,121,556 734,472 358,876 128,024 - 32,383,545 - % 5.86% 0.40% 3,850,600 158.98 157.90 3.32 3.30 0.00 0.00 8.4100 8.35   315.04%   137.16% 30-Sep-2022 4.48 2.82 134.75 0.53 0.74% 0.00% 24-Nov-2022 4.48 2.82 134.75 0.53 0.74% 0.00%
31-Dec-2022 25-Aug-2022 30-Jun-2022 2 5,686,447 398,425 110,332 -59,534 269,542 31,805,956 - % 1.94% -0.19% 3,850,600 147.68 146.68 -1.55 -1.54 7.00 6.95 8.2600 8.20   70.19%   89.44% 30-Jun-2022 4.54 3.07 -293.64 0.55 -0.34% 1.54% 25-Aug-2022 4.70 3.18 -303.99 0.57 -0.33% 1.49%
31-Dec-2022 26-May-2022 31-Mar-2022 1 4,213,859 12,398 -173,479 -199,681 - 31,805,956 - % -4.12% -0.63% 3,850,600 109.43 108.69 -5.19 -5.15 0.00 0.00 8.2600 8.20   -53.83%   39.81% 31-Mar-2022 4.68 4.28 -90.25 0.57 -1.11% 0.00% 26-May-2022 4.88 4.46 -94.10 0.59 -1.06% 0.00%
31-Dec-2021 24-Feb-2022 31-Dec-2021 4 4,837,629 301,466 46,775 -129,805 423,566 31,805,956 - % 0.97% -0.41% 3,850,600 125.63 124.78 -3.37 -3.35 11.00 10.93 8.2600 8.20   62.33%   -619.70% 31-Dec-2021 4.67 3.72 -138.53 0.57 -0.72% 2.36% 24-Feb-2022 4.50 3.58 -133.49 0.54 -0.75% 2.44%
31-Dec-2021 25-Nov-2021 30-Sep-2021 3 3,502,146 -278,302 -326,497 -344,553 - 32,152,511 - % -9.32% -1.07% 3,850,600 90.95 90.33 -8.95 -8.89 0.00 0.00 8.3500 8.29   38.86%   -163.53% 30-Sep-2021 5.04 5.54 -56.33 0.60 -1.78% 0.00% 25-Nov-2021 4.94 5.43 -55.21 0.59 -1.81% 0.00%
31-Dec-2021 27-Aug-2021 30-Jun-2021 2 2,936,692 -507,026 -598,968 -563,529 - 32,614,583 - % -20.40% -1.73% 3,850,600 76.27 75.75 -14.63 -14.54 0.00 0.00 8.4700 8.41   -69.86%   28.31% 30-Jun-2021 4.93 6.46 -33.69 0.58 -2.97% 0.00% 27-Aug-2021 4.93 6.46 -33.69 0.58 -2.97% 0.00%
31-Dec-2021 25-May-2021 31-Mar-2021 1 2,253,067 -486,920 -534,397 -331,759 - 33,076,654 - % -23.72% -1.00% 3,850,600 58.51 58.12 -8.62 -8.56 0.00 0.00 8.5900 8.53   -1,428.26%   -150.73% 31-Mar-2021 5.03 8.60 -58.38 0.59 -1.71% 0.00% 4.91 8.39 -56.99 0.57 -1.75% 0.00%
31-Dec-2020 25-Feb-2021 31-Dec-2020 4 3,048,075 291,869 155,428 24,977 327,301 32,961,137 1,310.41% 5.10% 0.08% 3,850,600 79.16 78.62 0.65 0.64 8.50 8.44 8.5600 8.50   119.10%   -95.28% 31-Dec-2020 4.46 5.63 687.58 0.52 0.15% 1.91% 25-Feb-2021 4.63 5.85 713.79 0.54 0.14% 1.84%
31-Dec-2020 26-Nov-2020 30-Sep-2020 3 3,298,829 60,044 -421,351 -130,746 - 33,230,678 - % -12.77% -0.39% 3,850,600 85.67 85.09 -3.40 -3.37 0.00 0.00 8.6300 8.57   83.37%   -142.77% 30-Sep-2020 3.18 3.71 -93.65 0.37 -1.07% 0.00% 26-Nov-2020 4.25 4.96 -125.17 0.49 -0.80% 0.00%
31-Dec-2020 27-Aug-2020 30-Jun-2020 2 1,107,938 -1,660,160 -1,465,111 -786,054 250,289 34,231,835 - % -132.24% -2.30% 3,850,600 28.77 28.58 -20.41 -20.28 6.50 6.46 8.8900 8.83   -494.06%   -231.08% 30-Jun-2020 4.10 14.25 -20.08 0.46 -4.98% 1.59% 27-Aug-2020 3.54 12.30 -17.34 0.40 -5.77% 1.84%
31-Dec-2020 21-May-2020 31-Mar-2020 1 4,109,218 -218,205 -342,943 -132,318 - 35,040,461 - % -8.35% -0.38% 3,850,600 106.72 105.99 -3.44 -3.41 0.00 0.00 9.1000 9.04   -125.02%   -123.56% 31-Mar-2020 3.75 3.51 -109.13 0.41 -0.92% 0.00% 21-May-2020 4.08 3.82 -118.73 0.45 -0.84% 0.00%
31-Dec-2019 27-Feb-2020 31-Dec-2019 4 5,303,023 1,119,541 935,220 528,822 596,843 35,348,509 112.86% 17.64% 1.50% 3,850,600 137.72 136.79 13.73 13.64 15.50 15.39 9.1800 9.12   73.00%   -19.28% 31-Dec-2019 6.05 4.39 44.05 0.66 2.27% 2.56% 27-Feb-2020 5.16 3.75 37.57 0.56 2.66% 3.00%
31-Dec-2019 28-Nov-2019 30-Sep-2019 3 5,294,994 954,053 717,534 305,682 - 34,809,423 - % 13.55% 0.88% 3,850,600 137.51 136.58 7.94 7.88 0.00 0.00 9.0400 8.98   -49.03%   210.84% 30-Sep-2019 5.74 4.17 72.31 0.63 1.38% 0.00% 28-Nov-2019 5.85 4.25 73.69 0.65 1.36% 0.00%
31-Dec-2019 29-Aug-2019 30-Jun-2019 2 5,445,725 1,329,898 1,056,978 599,679 250,289 34,770,916 41.74% 19.41% 1.72% 3,850,600 141.43 140.47 15.57 15.47 6.50 6.46 9.0300 8.97   6.77%   56.36% 28-Jun-2019 6.77 4.79 43.47 0.75 2.30% 0.96% 29-Aug-2019 5.90 4.17 37.88 0.65 2.64% 1.10%
31-Dec-2019 23-May-2019 31-Mar-2019 1 5,572,801 1,179,090 971,363 561,640 - 34,110,998 - % 17.43% 1.65% 3,850,000 144.75 143.74 14.59 14.49 0.00 0.00 8.8600 8.80   -14.27%   -6.81% 29-Mar-2019 6.64 4.59 45.52 0.75 2.20% 0.00% 23-May-2019 6.33 4.37 43.39 0.71 2.30% 0.00%
31-Dec-2018 27-Feb-2019 31-Dec-2018 4 5,397,445 1,129,085 1,234,309 655,161 500,578 34,270,338 76.41% 22.87% 1.91% 3,850,600 140.17 139.22 17.01 16.90 13.00 12.91 8.9000 8.84   337.55%   392.05% 31-Dec-2018 6.10 4.35 35.85 0.69 2.79% 2.13% 27-Feb-2019 7.32 5.22 43.02 0.82 2.32% 1.78%
31-Dec-2018 30-Nov-2018 30-Sep-2018 3 5,381,457 -268,563 -731,405 -275,799 - 33,634,896 - % -13.59% -0.82% 3,839,600 140.16 138.81 -7.18 -7.11 0.00 0.00 8.7600 8.68   -171.91%   -244.30% 28-Sep-2018 7.81 5.57 -108.73 0.89 -0.92% 0.00% 30-Nov-2018 6.28 4.48 -87.43 0.72 -1.14% 0.00%
31-Dec-2018 29-Aug-2018 30-Jun-2018 2 4,823,315 1,117,416 823,524 383,515 325,686 33,564,816 84.92% 17.07% 1.14% 3,831,600 125.88 124.41 10.01 9.89 8.50 8.40 8.7600 8.66   -36.37%   -15.96% 29-Jun-2018 8.41 6.68 84.02 0.96 1.19% 1.01% 29-Aug-2018 8.70 6.91 86.92 0.99 1.15% 0.98%
31-Dec-2018 24-May-2018 31-Mar-2018 1 5,250,756 1,440,460 1,117,441 602,704 - 33,391,697 - % 21.28% 1.80% 3,829,323 137.12 135.44 15.74 15.55 0.00 0.00 8.7200 8.61   352.65%   -9.83% 30-Mar-2018 8.73 6.37 55.47 1.00 1.80% 0.00% 24-May-2018 8.44 6.16 53.62 0.97 1.86% 0.00%
31-Dec-2017 27-Feb-2018 31-Dec-2017 4 5,258,638 835,302 590,278 133,150 497,284 33,777,124 373.48% 11.22% 0.39% 3,825,269 137.47 135.64 3.48 3.43 13.00 12.83 8.8300 8.71   -30.33%   -88.26% 29-Dec-2017 9.20 6.69 264.31 1.04 0.38% 1.41% 27-Feb-2018 8.99 6.54 258.27 1.02 0.39% 1.45%
31-Dec-2017 23-Nov-2017 30-Sep-2017 3 5,039,580 818,848 536,173 191,127 - 34,577,648 - % 10.64% 0.55% 3,799,741 132.63 129.99 5.03 4.93 0.00 0.00 9.1000 8.92   -58.12%   -66.70% 29-Sep-2017 9.55 7.20 189.86 1.05 0.53% 0.00% 23-Nov-2017 9.15 6.90 181.91 1.01 0.55% 0.00%
31-Dec-2017 24-Aug-2017 30-Jun-2017 2 4,953,177 1,148,694 883,349 456,332 318,982 34,562,646 69.90% 17.83% 1.32% 3,752,730 131.99 127.76 12.16 11.77 8.50 8.23 9.2100 8.91   -31.73%   57.45% 30-Jun-2017 9.41 7.13 77.38 1.02 1.29% 0.90% 24-Aug-2017 9.79 7.42 80.51 1.06 1.24% 0.87%
31-Dec-2017 29-May-2017 31-Mar-2017 1 4,768,599 1,513,740 1,237,341 668,421 - 33,503,442 - % 25.95% 2.00% 3,722,604 128.10 123.00 17.95 17.24 0.00 0.00 9.0000 8.64   -41.05%   410.91% 31-Mar-2017 9.59 7.49 53.41 1.07 1.87% 0.00% 29-May-2017 9.73 7.60 54.19 1.08 1.85% 0.00%
31-Dec-2016 23-Feb-2017 31-Dec-2016 4 4,753,054 2,752,335 2,392,931 1,133,898 465,462 33,997,381 41.05% 50.35% 3.34% 3,723,700 127.64 122.60 30.45 29.25 12.50 12.01 9.1300 8.77   97.54%   234.54% 30-Dec-2016 8.00 6.27 26.27 0.88 3.81% 1.56% 23-Feb-2017 9.08 7.11 29.82 0.99 3.35% 1.38%
31-Dec-2016 24-Nov-2016 30-Sep-2016 3 4,683,695 1,438,107 1,191,039 574,004 - 32,547,195 - % 25.43% 1.76% 3,723,935 125.77 120.81 15.41 14.81 0.00 0.00 8.7400 8.40   98.05%   58.96% 30-Sep-2016 7.93 6.31 51.45 0.91 1.94% 0.00% 24-Nov-2016 8.06 6.41 52.29 0.92 1.91% 0.00%
31-Dec-2016 25-Aug-2016 30-Jun-2016 2 4,225,390 742,512 602,757 289,822 - 31,443,463 - % 14.27% 0.92% 3,716,721 113.69 108.99 7.80 7.48 0.00 0.00 8.4600 8.11   121.53%   326.78% 30-Jun-2016 8.20 7.21 105.16 0.97 0.95% 0.00% 25-Aug-2016 8.21 7.22 105.29 0.97 0.95% 0.00%
31-Dec-2016 24-May-2016 31-Mar-2016 1 4,703,666 542,728 304,612 130,830 - 30,328,772 - % 6.48% 0.43% 3,716,761 126.55 121.33 3.52 3.37 0.00 0.00 8.1600 7.82   -61.40%   -78.90% 31-Mar-2016 9.80 7.74 278.41 1.20 0.36% 0.00% 24-May-2016 8.47 6.69 240.63 1.04 0.42% 0.00%
31-Dec-2015 23-Feb-2016 31-Dec-2015 4 4,919,421 726,691 612,640 338,946 130,077 32,630,984 38.38% 12.45% 1.04% 3,716,513 132.37 126.89 9.12 8.74 3.50 3.36 8.7800 8.42   -6.13%   23.78% 31-Dec-2015 7.34 5.55 80.48 0.84 1.24% 0.48% 23-Feb-2016 8.10 6.12 88.82 0.92 1.13% 0.43%
31-Dec-2015 26-Nov-2015 30-Sep-2015 3 4,645,440 1,077,994 767,105 361,097 - 32,242,131 - % 16.51% 1.12% 3,718,815 124.92 119.82 9.71 9.31 0.00 0.00 8.6700 8.32   431.74%   2.38% 30-Sep-2015 7.27 5.82 74.87 0.84 1.34% 0.00% 26-Nov-2015 7.30 5.84 75.18 0.84 1.33% 0.00%
31-Dec-2015 26-Aug-2015 30-Jun-2015 2 4,167,864 425,724 256,271 67,909 - 28,685,057 - % 6.15% 0.24% 3,710,874 112.31 107.51 1.83 1.75 0.00 0.00 7.7300 7.40   -89.05%   -81.75% 30-Jun-2015 8.06 7.18 440.44 1.04 0.23% 0.00% 26-Aug-2015 6.64 5.91 362.84 0.86 0.28% 0.00%
31-Dec-2015 28-May-2015 31-Mar-2015 1 4,367,631 1,215,588 961,661 620,060 - 28,289,308 - % 22.02% 2.19% 3,717,386 117.49 112.66 16.68 15.99 0.00 0.00 7.6100 7.30   126.43%   24.63% 31-Mar-2015 9.00 7.66 53.96 1.18 1.85% 0.00% 28-May-2015 8.50 7.23 50.96 1.12 1.96% 0.00%
31-Dec-2014 26-Feb-2015 31-Dec-2014 4 4,622,027 913,193 669,299 273,836 111,466 26,826,267 40.71% 14.48% 1.02% 3,715,549 124.40 119.22 7.37 7.06 3.00 2.88 7.2200 6.92   -22.36%   -43.40% 31-Dec-2014 8.87 7.13 120.35 1.23 0.83% 0.34% 26-Feb-2015 8.98 7.22 121.85 1.24 0.82% 0.33%
31-Dec-2014 21-Nov-2014 30-Sep-2014 3 4,492,316 953,932 680,110 352,700 - 25,829,978 - % 15.14% 1.37% 3,716,543 120.87 115.87 9.49 9.10 0.00 0.00 6.9500 6.66   -5.20%   -23.67% 30-Sep-2014 9.49 7.85 100.00 1.37 1.00% 0.00% 21-Nov-2014 9.40 7.78 99.05 1.35 1.01% 0.00%
31-Dec-2014 28-Aug-2014 30-Jun-2014 2 4,408,788 930,986 721,298 372,066 37,169 25,869,923 9.99% 16.36% 1.44% 3,716,942 118.61 113.72 10.01 9.60 1.00 0.96 6.9600 6.67   -25.22%   -20.21% 30-Jun-2014 9.99 8.42 99.80 1.44 1.00% 0.10% 28-Aug-2014 9.70 8.18 96.90 1.39 1.03% 0.10%
31-Dec-2014 29-May-2014 31-Mar-2014 1 4,693,367 1,464,238 1,075,419 497,531 - 26,025,838 - % 22.91% 1.91% 3,707,384 126.60 121.06 13.42 12.83 0.00 0.00 7.0200 6.71   2.83%   25.06% 31-Mar-2014 10.00 7.90 74.52 1.42 1.34% 0.00% 29-May-2014 9.80 7.74 73.03 1.40 1.37% 0.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Analyze this stock with MQ Trader system
  39 people like this.
 
Ytl2023 Coming 4.40. Thailand open new casino. Sure hailat. Which tourist come Malaysia. Malaysia own people like to go Thailand also
18/04/2024 10:38 AM
Ytl2023 Yes LKT sure want share taurx with u. Give u empire got la
18/04/2024 10:41 AM
OTB Posted by AngTayKor > 14 minutes ago | Report Abuse

@neohts, i believe in the potential of Taurx. But i have bought n sold GenB for so many rounds already. In fact last month i promptly reminded a few times here that the taurx news is just 24 mth result n not approval yet so dont get too carried away.
------------------
Even it is not approved, can the company sells this drug to make profit ?
The US is not a gentleman country, she will delay the final approval unless it is an US drug company.
Please advise.
Thank you.
18/04/2024 10:43 AM
lamkin Don't be naive to believe Taurx will have any benefit to Genting, LKT will make way to pocket it to his private entity.
18/04/2024 10:44 AM
Ytl2023 Those bought rm4.50- 4.60. Can average again
18/04/2024 10:47 AM
troy88 Taurx so far is proven to be all hype and no substance
18/04/2024 10:51 AM
OnTime genting =/= 云顶. genting == abyss.
18/04/2024 11:27 AM
Junichiro TAURX is a UK company. Genting is one of its shareholders.
18/04/2024 12:08 PM
prudentinvestor Buy bank counters if you want to sleep well.
18/04/2024 12:27 PM
AngTayKor Posted by Junichiro > 17 minutes ago | Report Abuse

TAURX is a UK company. Genting is one of its shareholders.
----------

Actually its a singapore company but base in UK
18/04/2024 12:27 PM
AngTayKor If no approval, of course much harder to sell the drug. However, HMTM is now available at HK under paid compassionate program. Taurx now applying to expand this program to other China territories like Macau guangdong region.

Unless LKT willing to sell out his 21% stake to SWF n crystalise the usd2b investment (probable value then) into cash after UAE CA, else its just a paper profit not even reflected in accounting books (probably still recorded at cost price).

Abt USA FDA, I believe its easier for FDA to approve weak problematic drugs developed by American pharmas like Biogen / Eli, than to reject a good drug with no side effects (especially after Tofersen's approval has opened a precedence for HMTM to follow using the AA pathway).
18/04/2024 12:30 PM
Junichiro @ATK.. Thanks for enlightening me.
18/04/2024 12:31 PM
neohts AngTayKor,
HMTM is now available at HK under paid compassionate program. Taurx now applying to expand this program to other China territories like Macau guangdong region.

Can TauRX selling in China and south east Asia even without approval from FDA ?
18/04/2024 12:36 PM
AngTayKor Just look at mci patient group. At 18 mths we are still able to reversal back upwards n performing above the initial start point scores. Lecanemab can only slowdown by 27% n still declining at 73% + brain bleeding + brain shrinkage. HMTM can stop the decline + reverse back upwards.
18/04/2024 12:36 PM
AngTayKor @neohts, if no FDA approval but secure EMA CA, I believe can eventually sell to most territories except USA. Countries can also choose to follow EMA's decision.
18/04/2024 12:41 PM
investopology genting really hit the 4.44 to close the gap. might rebounding next week. and after the good news announce and good QR coming it should be able to rebound soon.
18/04/2024 1:27 PM
Boon Keng Genting operator cunning, purposesly press down to let shareholder throw and they collect back your cheap ticket. and give u dividend as sweet of memories.
18/04/2024 1:28 PM
EngineeringProfit Can slowly recollect fro another ride.....no hurry
18/04/2024 1:29 PM
VincentTang Genting Singapore start reverse from botton and up 3.3% today. Is time to buy GENM and GENTING now.
18/04/2024 1:43 PM
AngTayKor Posted by prudentinvestor > 1 hour ago | Report Abuse
Buy bank counters if you want to sleep well.
-------------

Powell backing away from rate cuts good for banking stocks
18/04/2024 2:08 PM
AngTayKor GenS moving up in anticipation of MBS result next week
18/04/2024 2:09 PM
speakup Almost want cut loss at 4.40. Good thing didn't hit cut loss
18/04/2024 3:56 PM
Shines GenS AGm, fixing div dates
18/04/2024 4:04 PM
neohts Still no strong support. Too many seller at the end of the day. Buyer keep buying selling keep showing up.
18/04/2024 8:49 PM
AngTayKor Could be an illusion to create mkt confusion? 😀

I like to see my "sister's behaviour" sometimes.
18/04/2024 9:06 PM
newbie2019 erh…. where is my 4.37
18/04/2024 9:39 PM
Johnchew123 4.38 soon ,u will see it , safe Buy in 4.28 - 4.38 , this level will consolidate , curent trend is downtrend , du beli ,du simpan , du contra , du rugi , wait trend consolidate n see reverse point
19/04/2024 8:28 AM
rohank71 any comments on Thailand opening up casino there and its impact on both GM and GS? Can anyone share.
19/04/2024 8:36 AM
rohank71 is this the main reason for the sell down recently.
19/04/2024 8:38 AM
neohts Thailand not so soon, may take many years.
Genting Singapore have the chance to tender for the casino together with Thailand
19/04/2024 8:51 AM
Save Genting MAV 200 is 4.39, why need to cut loss at 4.40? Genting already test the gap up on 24/11/23 yesterday, it may retest the MAV200 before real rebound. Forming double bottoms at 4.39 is great.
19/04/2024 9:11 AM
troy88 Looks like it will hover in this yoyo range for some time..
19/04/2024 9:17 AM
cactus81 Many people wonder when can get the approval for Taurx Alzheimer medicine. For me the most important is whether the medicine is safety and effectiveness. The result show these two pint already. Try to think about it if you are an Alzheimer patient. What will you do if you know there is a drug which can delay deterioration of your condition or even reverse it if you at at very early stage? Is it worth to hold Taurx or Genting berhad due to accessibility
19/04/2024 9:57 AM
cactus81 What will be India and China GDP when Thailand casino are ready? It will be much better than now. Question now is how to get a pie from Thailand plan.
19/04/2024 10:00 AM
neohts Bought 4.47 using today dividend money.
19/04/2024 10:30 AM
CharlesT OTB's earlier buy calls on both Genm n Genting really puzzles me....

Seems Sifu doesnt undesrtand Lim Kok Thai n his Cos' shares price pattern at all.....
19/04/2024 10:32 AM
Ytl2023 Coming. Ur 4.37. Be patient. Many counter cheap sales now
19/04/2024 11:02 AM
Johnchew123 Iran sudah kena BOMB atom israel , koyak all Asia stock
19/04/2024 11:27 AM
keyman Hahaha lni kali lah... 机会来了🤭
19/04/2024 11:33 AM
prudentinvestor Those who didn't buy Genting when it dipped below RM3 in 2020 might have the opportunity this time. 有危机才有机会。
19/04/2024 11:52 AM
Junichiro Escalation in Middle East - Israel carried out strikes on Iran, explosions were heard in the cities of Tehran, Isfahan, and Shiraz, as per local media reports.
19/04/2024 12:24 PM
OnTime israel is quite cunny, this's only the 1st wave. pretty sure the big hit is coming when least expected.
19/04/2024 2:35 PM
prudentinvestor Israel can count on US help, even direct military involvement. Iran has to be on its own.
19/04/2024 3:17 PM
Ytl2023 Pls wait until rm4. Ini baru beginning.
19/04/2024 3:23 PM
newbie2019 Ok…. 4.37 dont buy liao…4 buy a bit….3.50 if jadi show hand like ATK Sifu liao (I sold pant)
19/04/2024 8:52 PM
choysun LVS sell down due to Macau reno cost gua?
19/04/2024 9:45 PM
AngTayKor Please dont follow my reckless punting la. Bet showhand wrongly become beggar liow. Some years ago, i was waiting patiently for this stock's downtrend to fully playout. From 3.50 waited patiently to 3.00 chart point zone. It went even lower than 3.00 to scare off everyone. Thats when the brave ones should have strong courage n scoop up the shares with both hands (bring gunny sack also). Sibei soong ah...

Actually MBS Q1 result not bad leh, but LVS kena selldown 5%. Up to the whales to play the prevailing storyline n stock market. Follow the trend until it bends.
19/04/2024 9:46 PM
choysun Iran-Israel tension calming dy. Next week still got discount ah? :p
19/04/2024 9:46 PM
AngTayKor Iran took 2 weeks to retaliate. Israel maybe also? I think better becareful of "Sell In May" this yr.
19/04/2024 9:50 PM
choysun Yeah, watching for May :)
19/04/2024 10:07 PM